Indeed, experimental evidence suggests that coronavirus N protein:MASP-2 interaction leads to an uncontrolled activation of the complement lectin pathway (14), and, recently, complement was postulated as a target for therapy in COVID-19 patients (15). Here, MASP2 is linked to COVID-19.